Partnership Opportunities

The Premium Platform to Foster New & Existing Relationships Within the Rapidly Expanding Radiopharmaceuticals Field

While the industry has had to overcome some seriously complex translational, clinical and supply chain challenges to drive the success of the approved radiopharmaceutical therapies currently on the market, the obstacles don’t stop there.

The mature field seeks to optimize its clinical capabilities and continues the battle to secure clinical supply chain. Others are looking towards novel targets and new radioisotopes to prevent competition, but these drug developers need the support from service providers to do so.

Whether you’re supporting target identification, screening and pre-clinical models, supplying cyclotron equipment, isotope synthesis, providing nuclides, chelation services, preclinical and clinical imaging services, nuclear medicine clinical research or radiopharmaceutical CDMO capabilities - our attendees want to meet you!

The 3rd Targeted Radiopharmaceuticals Summit US is uniting the leading players across Novartis, Bayer, AstraZeneca, ARTBIO, OranoMed, Perspective Therapeutics, Abdera and more to explore how to attain significant clinical efficacy of their TRP pipelines by matching advances in next generation targets with innovations in quantitative imaging & isotope supply.

If you would like to align your brand with the radiopharmaceuticals space and showcase your technical expertise with these passionate individuals with a set of unique challenges, we can collaborate with you to establish new connections through a bespoke commercial partnership to help you achieve your specific business needs within this space in the future.

Screenshot 2023-05-30 103209
Screenshot 2023-05-30 104908

Who Attends:

48450 - Types of Companies
48450 - Senior